Daniel Barber | executive |
Ernie Toth | executive |
François Brisebois | analyst |
Carl Kraus | executive |
Jason Butler | analyst |
Andreas Argyrides | analyst |
Thomas Flaten | analyst |
Raghuram Selvaraju | analyst |
James Molloy | analyst |
Good morning, and welcome to Aquestive Therapeutics Fourth Quarter and Full Year 2023 Conference Call. [Operator Instructions] As a reminder, this call will be recorded.
I would now like to introduce your host for today's conference call, Bennett Watson of ICR Westwicke Investor Relations. Please go ahead.
Thank you, operator.